ATF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.258600E-01
Normal-vs-Stage2
8.864000E-01
Normal-vs-Stage3
4.667400E-01
Normal-vs-Stage4
6.711600E-01
Stage1-vs-Stage2
8.868000E-01
Stage1-vs-Stage3
3.718800E-01
Stage1-vs-Stage4
3.597400E-01
Stage2-vs-Stage3
2.774200E-01
Stage2-vs-Stage4
3.780400E-01
Stage3-vs-Stage4
1.848990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.537000E-01
Normal-vs-AfricanAmerican
9.111000E-01
Normal-vs-Asian
4.676000E-01
Caucasian-vs-AfricanAmerican
6.563600E-01
Caucasian-vs-Asian
2.772400E-01
AfricanAmerican-vs-Asian
2.314600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.391000E-01
Normal-vs-Female
6.970400E-01
Male-vs-Female
3.162000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.150800E-01
Normal-vs-Age(41-60Yrs)
8.204000E-01
Normal-vs-Age(61-80Yrs)
7.440600E-01
Normal-vs-Age(81-100Yrs)
5.630400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.777560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.180600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.720000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.082100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.418100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.807600E-01
Normal-vs-Daily Drinker
4.732400E-01
Normal-vs-Weekly Drinker
6.133000E-01
Normal-vs-Occasional Drinker
8.389400E-01
Normal-vs-Social Drinker
8.963000E-01
Non Drinker-vs-Daily Drinker
6.303400E-01
Non Drinker-vs-Weekly Drinker
9.775600E-01
Non Drinker-vs-Occasional Drinker
1.215160E-01
Non Drinker-vs-Social Drinker
3.749000E-01
Daily Drinker-vs-Weekly Drinker
6.725600E-01
Daily Drinker-vs-Occasional Drinker
7.327700E-02
Daily Drinker-vs-Social Drinker
2.170800E-01
Weekly Drinker-vs-Occasional Drinker
2.067800E-01
Weekly Drinker-vs-Social Drinker
4.435200E-01
Occasional Drinker-vs-Social Drinker
5.262200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.089800E-01
Normal-vs-Grade 2
5.709800E-02
Normal-vs-Grade 3
3.670200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.400630E-01
Grade 1-vs-Grade 3
1.533180E-01
Grade 1-vs-Grade 4
1.089800E-01
Grade 2-vs-Grade 3
9.614200E-01
Grade 2-vs-Grade 4
5.709800E-02
Grade 3-vs-Grade 4
3.670200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.217000E-01
Normal-vs-NonDiabetic
7.205400E-01
Diabetic-vs-NonDiabetic
5.109600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.395200E-01
Normal-vs-NoPancreatitis
7.260200E-01
Pancreatitis-vs-NoPancreatitis
9.448400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.388800E-01
Normal-vs-N1
9.515400E-01
N0-vs-N1
1.989230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.146400E-01
Normal-vs-TP53-NonMutant
9.643800E-01
TP53-Mutant-vs-TP53-NonMutant
1.528180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
